Page 1 of 122Free preview · 1–5

About this document

Guidance effective July 6, 2026, addressing Medicare Part C and Part D enrollee grievances, coverage and organization determinations, and appeals under 42 CFR Part 422 Subpart M and Part 423 Subparts M and U. The supplied excerpt explains plan responsibilities, enrollee representation, grievance handling, prior authorization, Part D exceptions, processing deadlines, notification requirements, dismissals, and the beginning of level 1 appeal procedures. The table of contents also lists higher-level appeals, reopenings, effectuation, provider notices, and appendices. The document states that it does not have the force and effect of law unless specifically incorporated into a contract.

Free preview text

The first 5 pages, shown as text so search engines and readers can find this document.

Page 1

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. i 10 – Introduction ........................................................................................................................................... 6 10.1 – Glossary ......................................................................................................................................... 6 10.2 – Applicability to Employer-Sponsored Benefits ............................................................................. 9 10.3 – Claims Processing and Appeals for Medicare Cost Plans and Health Care Prepayment Plans (HCPPs) .................................................................................................................................................... 9 10.4 – General Responsibilities of the Plan ............................................................................................ 10 10.4.1 – Medical Exigency Standard .................................................................................................. 10 10.4.2 – Role of the Medical Director................................................................................................. 11 10.4.3 – Delegation of Responsibilities .............................................................................................. 11 10.4.4 – Plan Communication to an Enrollee ..................................................................................... 11 10.5 – Adjudication Requirements.......................................................................................................... 13 10.5.1 –Calculation of Days for Assessing Plan Timeliness............................................................... 13 10.5.2 – When a Request is Considered Received by the Plan ........................................................... 13 10.5.3 – When Notification is Considered Delivered by the Plan ...................................................... 14 10.6 – Outreach for Additional Information to Support Coverage Decisions ........................................ 15 20 – Representatives ................................................................................................................................... 16 20.1 – Representatives Filing on Behalf of Enrollees ............................................................................. 16 20.2 – Appointment of Representative (AOR) Form or Equivalent Written Notice .............................. 17 20.2.1 – Missing or Defective Representative Form........................................................................... 18 20.3 – Authority of a Representative ...................................................................................................... 19 30 – Grievances........................................................................................................................................... 19 30.1 – Classification between Grievances, Inquiries, Coverage Requests, and Appeals ........................ 19 30.1.1 – Inquiries Related to Non-Part D and Excluded Drugs (Part D Only) ................................... 22 30.2 – Procedures for Handling a Grievance .......................................................................................... 23 30.2.1 – Notification Requirements for Grievances............................................................................ 24 30.3 – Quality of Care Grievances .......................................................................................................... 24 30.3.1 – Procedures for Handling a Quality of Care Grievance .................................................... 25 Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance Effective July 6, 2026 Table of Contents

Page 2

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. ii 30.4 – Procedure for Handling Withdrawn Grievances .......................................................................... 26 40 – Coverage Determinations, Organization Determinations (Initial Determinations) and At-Risk Determinations ............................................................................................................................................ 26 40.1 – Part C Organization Determinations ............................................................................................ 27 40.2 – Part D Coverage Determinations ................................................................................................. 28 40.3 – Part D At-Risk Determinations .................................................................................................... 28 40.4 – Prior Authorization and Other Utilization Management Requirements....................................... 29 40.5 – Part D Exceptions ........................................................................................................................ 31 40.5.1 – Tiering Exceptions ................................................................................................................ 31 40.5.2 – Formulary Exceptions ........................................................................................................... 32 40.5.3 – Supporting Statements for Exception Requests .................................................................... 33 40.5.4 – Adjudication Timeframes for Coverage Determinations Involving an Exception................ 34 40.5.5 – Approval of an Exception Request ....................................................................................... 36 40.5.6 – Approval of a Tiering Exception Request............................................................................. 37 40.6 – Who May Request an Initial Determination ................................................................................ 38 40.7 – Guidelines for Accepting Initial Determination Requests ........................................................... 38 40.8 – How to Process Requests for Expedited Initial Determinations .................................................. 40 40.9 – Who Must Review an Initial Determination ................................................................................ 43 40.10 – Processing Timeframes .............................................................................................................. 44 40.11 – Effect of Failure to Meet the Timeframe for an Initial Determination ...................................... 45 40.12 – Notification Requirements for Initial Determinations ............................................................... 47 40.12.1 – Part C Notification Requirements ....................................................................................... 47 40.12.2 – Part D Notification Requirements ....................................................................................... 51 40.12.3 – Part D Coverage Determination Notices ............................................................................. 53 40.13 – Procedures for Handling Misclassified Initial Determinations .................................................. 56 40.14 – Withdrawal of an Initial Determination Request ....................................................................... 57 40.15 – Dismissal of an Initial Determination Request .......................................................................... 57 40.15.1 – Dismissal Notice ................................................................................................................. 58 40.15.2 – Dismissal Binding Unless Modified, Reversed or Vacated ................................................ 58 50 – Reconsiderations and Redeterminations (Level 1 Appeals) ............................................................... 60 50.1 – Who May Request a Level 1 Appeal ........................................................................................... 61 50.1.1 – Requirements for Provider Claim Appeals (Part C Only)..................................................... 62 50.2 – Level 1 Appeal Requests.............................................................................................................. 64 50.2.1 – Guidelines for Accepting Level 1 Appeal Requests ............................................................. 64

Page 3

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. iii 50.2.2 – How to Process Requests for Expedited Level 1 Appeals .................................................... 66 50.3 – Good Cause Exception for Late Filing ........................................................................................ 71 50.4 – Withdrawal of a Level 1 Appeal Request .................................................................................... 73 50.5 – Actions the Appealing Party Can Take During a Level 1 Appeal ............................................... 73 50.5.1 – Opportunity to Submit Evidence........................................................................................... 73 50.5.2 –Enrollee Request for Case File Content ................................................................................. 73 50.6 – Who Must Conduct a Level 1 Appeal .......................................................................................... 74 50.7 – Conducting a Level 1 Appeal....................................................................................................... 74 50.7.1 – Processing Timeframes ......................................................................................................... 75 50.7.2 – Effect of Failure to Meet the Timeframe for Level 1 Appeals.............................................. 76 50.8 – Service or Benefit Received Prior to Notice of Decision ............................................................ 77 50.9 – Dismissal of a Level 1 Appeal Request ....................................................................................... 77 50.9.1 – Dismissal Notice ................................................................................................................... 79 50.9.2 – Dismissal Binding Unless Modified, Reversed or Vacated .................................................. 79 50.10 – Notification Requirements for Level 1 Appeal Decisions ......................................................... 80 50.10.1 - Part C Notification Requirements ........................................................................................ 80 50.10.2 - Part D Notification Requirements........................................................................................ 81 50.11 – Procedure for Handling Misclassified Appeals.......................................................................... 83 50.12 – Timeframes and Responsibilities for Forwarding Case Files to the Independent Review Entity ................................................................................................................................................................ 83 50.12.1 – Forwarding Case Files – Plan Responsibilities ................................................................... 83 50.12.2 – Forwarding Case Files - Timeframes .................................................................................. 84 50.12.3 – Preparing the Case File for the Independent Review Entity ............................................... 85 50.12.4 – Including Evidence of Coverage and Formulary in Case Files........................................... 86 60 – Reconsiderations by the Independent Review Entity (Level 2 Appeal) ............................................. 87 60.1 – Who May Request a Level 2 Appeal ........................................................................................... 87 60.2 – How to Request a Level 2 Appeal (Part D Only)......................................................................... 87 60.3 – Processing Timeframes ................................................................................................................ 88 60.4 – Good Cause Extension (Part D Only) .......................................................................................... 88 60.5 – IRE Notification and Retention Requirements ............................................................................ 88 60.6 – Dismissal of a Level 2 Appeal Request ....................................................................................... 89 60.6.1 – Dismissal Notice ................................................................................................................... 89 60.6.2 – Dismissal Binding Unless Modified, Reversed or Vacated .................................................. 90 60.7 – Effect of a Level 2 Appeal Determination ................................................................................... 90

Page 4

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. iv 60.8 – Reconsideration of Late Enrollment Penalty Determinations ...................................................... 91 60.8.1 – Summary of the LEP Reconsideration Process ..................................................................... 92 60.8.2 – Part D Plan Responsibilities under the LEP Reconsideration Process.................................. 93 60.8.3 – Requests for Information ...................................................................................................... 94 60.8.4 – Reasons for Requesting LEP Reconsideration and Presentation of Evidence ...................... 94 60.8.5 – IRE LEP Processing Timeframes.......................................................................................... 95 60.8.6 – Withdrawal of an LEP Reconsideration Request .................................................................. 96 60.8.7 - Dismissal of an LEP Reconsideration Request...................................................................... 96 70 – Key Aspects of Administrative Law Judge (ALJ)/Attorney Adjudicator, Council, and Judicial Review ........................................................................................................................................................ 97 70.1 – Parties to a Hearing ...................................................................................................................... 97 70.2 – Amount in Controversy................................................................................................................ 97 70.3 – Filing Requests for Review .......................................................................................................... 98 70.4 – Review Procedures..................................................................................................................... 101 70.4.1 – Decision-Making Timeframes ............................................................................................ 101 70.4.2 – Part D Plan Sponsor, CMS, or IRE Requesting ALJ Hearing Participation (Part D Only) 102 70.4.3 – Submitting Evidence at the Third Level of Review ............................................................ 103 80 – Reopening and Revising Determinations and Decisions .................................................................. 103 80.1 – Guidelines for Reopening .......................................................................................................... 104 80.2 – Reopenings Separate and Distinct from Appeals ....................................................................... 105 80.3 – Timeframes for Reopening ........................................................................................................ 106 80.3.1 – Timeframes for Initiating a Reopening ............................................................................... 106 80.3.2 – Timeframes for Processing a Reopening ............................................................................ 107 80.4 – Reopening Based on Clerical Error ........................................................................................... 107 80.5 – Good Cause for Reopening ........................................................................................................ 108 80.5.1 – New and Material Evidence ................................................................................................ 109 80.5.1.1 – Prohibition on Reopening a Previously Approved Inpatient Hospital Admission Based on New and Material Evidence ..................................................................................................... 109 80.6 – Notification Requirements for Reopenings................................................................................ 110 90 – Effectuation ....................................................................................................................................... 111 90.1 – Independent Review Entity Monitoring of Effectuation Requirements..................................... 112 90.2 – Effectuation Requirements for Former Plans............................................................................. 113 100 – Provider Notices in Hospital, SNF, HHA, and CORF Settings (Part C Only) ............................... 113 100.1 – Hospital Settings – Important Message from Medicare and Detailed Notice .......................... 113

Page 5

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. v 100.1.1 MA Plan Responsibilities Following BFCC-QIO Notification of Appeal .......................... 114 100.2 – Skilled Nursing Facility (SNF), Home Health (HH), and Comprehensive Outpatient Rehabilitation Services (CORF) Settings ............................................................................................. 114 100.2.1 – MA Plan Responsibilities Following BFCC-QIO Notification of Appeal........................ 115 100.3 – Part A Medicare Outpatient Observation Notice (MOON) ..................................................... 116 110 – Part C Data ...................................................................................................................................... 116 Appendices................................................................................................................................................ 118 Appendix 1 – Medicare Managed Care (Part C) Appeals Process Overview....................................... 118 Appendix 2 – Medicare Prescription Drug (Part D) Appeals Process Overview ................................. 119 Appendix 3 – Inpatient Hospital Admission Denial Appeal Access Chart........................................... 120 Appendix 4 – Resources ....................................................................................................................... 122

Tags

Doxxly editorial guide

Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance: summary, contents and background

This guide helps you understand the scope of Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance is a 122-page documentcredited to Petra J. Ellwood. Guidance effective July 6, 2026, addressing Medicare Part C and Part D enrollee grievances, coverage and organization determinations, and appeals under 42 CFR Part 422 Subpart M and Part 423 Subparts M and U. The supplied excerpt explains plan responsibilities, enrollee representation, grievance handling, prior authorization, Part D exceptions, processing deadlines, notification requirements, dismissals, and the beginning of level 1 appeal procedures. The table of contents also lists higher-level appeals, reopenings, effectuation, provider notices, and appendices. The document states that it does not have the force and effect of law unless specifically incorporated into a contract. It appears in the Law & Legal Studies collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Medicare Part C, Medicare Part D, Medicare Advantage, Enrollee grievances, Coverage determinations, Organization determinations, Appeals, Prior authorization, Prescription drug coverage, Plan responsibilities with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Medicare Part C, Medicare Part D, Medicare Advantage, Enrollee grievances, Coverage determinations, Organization determinations, Appeals, Prior authorization, Prescription drug coverage, Plan responsibilities. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 122 pages in the player.

  1. Part 1

    Medicare Part C

    Use this section of the reading guide to identify how Medicare Part C appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Medicare Part D

    Use this section of the reading guide to identify how Medicare Part D appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Medicare Advantage

    Use this section of the reading guide to identify how Medicare Advantage appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Enrollee grievances

    Use this section of the reading guide to identify how Enrollee grievances appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    Coverage determinations

    Use this section of the reading guide to identify how Coverage determinations appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    Organization determinations

    Use this section of the reading guide to identify how Organization determinations appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    Appeals

    Use this section of the reading guide to identify how Appeals appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Prior authorization

    Use this section of the reading guide to identify how Prior authorization appears in Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Petra J. Ellwood

Doxxly credits Petra J. Ellwood as the author or creator of Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is cms.gov. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit cms.gov

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Law & Legal Studies collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Law & Legal Studies resources

Frequently asked questions about Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Law & Legal Studies